by Sue Robbins | Jul 8, 2016 | Migraine
According to the American Headache Society, nearly 90% of self-diagnosed “sinus headaches” are actually migraines. And, there’s a difference between episodic and chronic migraine. Why does that matter? Treatments vary depending on the cause of your...
by Sue Robbins | Jun 13, 2016 | Headache Drugs
The US Food and Drug Administration (FDA) is looking into the risk for serious burns and potential permanent scarring with the use of the sumatriptan transdermal patch Zecuity. A single-use, battery-powered patch, Zecuity offers relief of migraine headache pain as...
by Sue Robbins | Feb 21, 2016 | Migraine
According to research published in Cephalagia, too much time in front of electronic screens can increase the risk of headaches and migraine in young adults. Previous studies have found associations between screen time exposure and headaches in children between the...
by Sue Robbins | Feb 1, 2016 | Migraine
The US Food and Drug Administration (FDA) has approved a low-dose sumatriptan powder delivered intranasally for the treatment of migraine with or without aura in adult patients. “Onzetra Xsail provides a new and much needed treatment option for what can be a...
by Sue Robbins | Dec 31, 2015 | Migraine
Helene Stapinski describes a time when her daughter had a headache, and she realized she had experienced the same condition when she was a young girl. Here is a part of her story…. A few months ago, my 10-year old daughter, Paulina was suffering from a bad...
